← Back to Vaccine Database

Ad5-nCoV

Viral vector (Non-replicating) vaccine · VDDBV0051

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials18

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT04313127 Phase 1COVID-19
NCT04568811 Phase 1COVID-19
NCT04552366 Phase 1COVID-19
NCT04398147 Phase 2COVID-19
NCT04840992 Phase 2COVID-19
NCT05043259 Phase 2COVID-19
NCT04566770 Phase 2COVID-19
NCT05293223 Phase 2COVID-19
NCT04341389 Phase 2COVID-19
NCT05162482 Phase 2COVID-19
NCT05005156 Phase 2COVID-19
NCT04954092 Phase 3COVID-19
NCT04526990 Phase 3COVID-19
NCT04540419 Phase 3COVID-19
NCT05169008 Phase 3COVID-19
NCT04892459 ApprovedCOVID-19
NCT05303584 ApprovedCOVID-19
NCT05313646 ApprovedCOVID-19